Feed VICO.ST
VI

Vicore Pharma Holding AB (publ) VICO.ST · STO

8.91 kr -0.78% (-0.07 kr)

Summary

35 / 100 · Bulios Score

What speaks for it

  • It has no debt and holds 428.6M kr in cash.
  • The price moves less than the market (beta 0.15).

What to watch

  • The company made a loss over the last 12 months.
  • It passes only 1 of the 9 points of the Piotroski financial health test.
  • It missed profit estimates 6 times in the last 8 quarters.
  • Analysts expect revenue to fall by 8.5% this fiscal year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (SEK)

Diluted EPS (SEK)

  • Analyst estimate

For the next fiscal year analysts expect revenue to fall by 8.5%.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of 502.0M kr.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.